Vertex Pharmaceuticals, Inc. (VRTX)
455.76
+3.72
(+0.82%)
USD |
NASDAQ |
Dec 15, 16:00
456.00
+0.24
(+0.05%)
After-Hours: 19:06
Vertex Pharmaceuticals Research and Development Expense (Annual): 3.630B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Amgen, Inc. | 5.676B |
| Eli Lilly & Co. | 10.99B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Moderna, Inc. | 4.354B |